MYDA Advisors’s DNA X Inc SONM Stock Holding History

MYDA Advisors’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28	Closed	-$186K	–	161
2019 Q4	$186K	Sell	28 -28	-50%	-$138K	0.08%	99
2019 Q3	$293K	Buy	56 +37	+195%	+$568K	0.13%	81
2019 Q2	$446K	Buy	+19	New	+$482K	0.15%	75

Other funds holding SONM

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AIM

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

MYDA Advisors's SONM Position: Q1 2020 in Review

MYDA Advisors sold out of DNA X Inc (SONM) in Q1 2020, closing a stake of 28 shares — an estimated $186K sold.

MYDA Advisors first reported a position in SONM in Q2 2019 and held it in 3 quarters. The position peaked at $446K in Q2 2019. 37 funds tracked by Wall St. Rank hold SONM as of Q1 2020.

MYDA Advisors reported no remaining DNA X Inc position as of Q1 2020 after selling out during the quarter.
MYDA Advisors sold 28 DNA X Inc shares in Q1 2020, an estimated $186K.
MYDA Advisors first reported a position in DNA X Inc in Q2 2019 and held it in 3 quarters.
MYDA Advisors's DNA X Inc position peaked at $446K in Q2 2019.
37 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2020.

Based on MYDA Advisors's 13F filing for Q1 2020, filed 14 May 2020.